文献速递心脑血管急症重症综合管理与镇静镇痛

早期神经功能无改善可预测急性脑出血不良预后

Lack of Early Improvement Predicts Poor Outcome Following Acute Intracerebral Hemorrhage.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论急性脑出血患者24小时美国国立卫生研究院卒中量表评分变化≥0分(无临床改善)可稳健预测90天不良预后,调整比值比5.05(95%CI 3.25-7.85)。

研究基于虚拟国际卒中试验档案库552例急性脑出血患者(发病<6小时)回顾性分析,在PREDICT前瞻性多中心队列275例中验证,旨在推导并验证早期神经功能变化预测90天预后的最佳阈值。以24小时美国国立卫生研究院卒中量表评分变化构建受试者工作特征曲线,主要终点为90天改良Rankin量表评分4-6分,曲线下面积0.75,约登指数最佳切点为-0.5,对应美国国立卫生研究院卒中量表评分变化≥0分(无临床改善),见于46%患者。该定义预测不良预后敏感度65%、特异度73%、阳性预测值70%、调整比值比5.05(95%CI 3.25-7.85);变化≥4分者敏感度19%、特异度98%、阳性预测值91%、调整比值比12.24(95%CI 4.08-36.66)。所有定义在验证队列中均重现良好。

要点

  • 急性脑出血发病<6小时患者,24小时美国国立卫生研究院卒中量表评分变化≥0分(无临床改善)预测90天改良Rankin量表4-6分,调整比值比5.05(95%CI 3.25-7.85)。
  • 24小时美国国立卫生研究院卒中量表评分变化预测90天不良预后的受试者工作特征曲线下面积为0.75。
  • 美国国立卫生研究院卒中量表评分变化≥0分见于46%患者,预测不良预后敏感度65%、特异度73%、阳性预测值70%。
  • 评分变化≥4分预测不良预后特异度98%、阳性预测值91%、调整比值比12.24(95%CI 4.08-36.66),但敏感度仅19%。
  • 所有定义在PREDICT验证队列(275例)中重现良好,可用于预后判断及作为未来脑出血治疗试验的早期替代终点。

适用人群与场景

  • 急性脑出血发病<6小时的患者,来自神经重症监护室和重症监护室;推导队列552例,验证队列275例。

诊断标准与关键阈值

  • 24小时美国国立卫生研究院卒中量表评分变化≥0分(无临床改善)为预测90天改良Rankin量表评分4-6分的最佳切点(约登指数切点-0.5)。
  • 24小时美国国立卫生研究院卒中量表评分变化≥4分也可预测不良预后,但敏感度低。

研究设计与关键结果

  • 回顾性分析虚拟国际卒中试验档案库552例急性脑出血患者推导,并在PREDICT前瞻性多中心队列275例中验证。
  • 主要终点为90天改良Rankin量表评分4-6分;24小时美国国立卫生研究院卒中量表评分变化与90天预后强相关,受试者工作特征曲线下面积0.75。
  • 美国国立卫生研究院卒中量表评分变化≥0分(无临床改善)见于46%患者,预测不良预后敏感度65%、特异度73%、阳性预测值70%、调整比值比5.05(95%CI 3.25-7.85)。
  • 美国国立卫生研究院卒中量表评分变化≥4分预测不良预后敏感度19%、特异度98%、阳性预测值91%、调整比值比12.24(95%CI 4.08-36.66)。
  • 所有定义在验证队列中重现良好。

证据类型、等级与局限

  • 证据类型:推导队列为回顾性分析(虚拟国际卒中试验档案库汇总数据),验证队列为前瞻性多中心队列研究(PREDICT)的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于急性脑出血发病<6小时的患者,24小时美国国立卫生研究院卒中量表评分无改善(变化≥0分)可稳健预测90天不良预后,有助于床旁预后判断。
  • 作者认为该发现可用于预后判断,并可能作为未来脑出血治疗试验的早期替代终点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: There are limited data as to what degree of early neurologic change best relates to outcome in acute intracerebral hemorrhage. We aimed to derive and validate a threshold for early postintracerebral hemorrhage change that best predicts 90-day outcomes.

DESIGN: Derivation: retrospective analysis of collated clinical stroke trial data (Virtual International Stroke Trials Archive).

VALIDATION: retrospective analysis of a prospective multicenter cohort study (Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign [PREDICT]).

SETTING: Neurocritical and ICUs.

PATIENTS: Patients with acute intracerebral hemorrhage presenting less than 6 hours. Derivation: 552 patients; validation: 275 patients.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We generated a receiver operating characteristic curve for the association between 24-hour National Institutes of Health Stroke Scale change and clinical outcome. The primary outcome was a modified Rankin Scale score of 4-6 at 90 days; secondary outcomes were other modified Rankin Scale score ranges (modified Rankin Scale, 2-6, 3-6, 5-6, 6). We employed Youden's J Index to select optimal cut points and calculated sensitivity, specificity, and predictive values. We determined independent predictors via multivariable logistic regression. The derived definitions were validated in the PREDICT cohort. Twenty-four-hour National Institutes of Health Stroke Scale change was strongly associated with 90-day outcome with an area under the receiver operating characteristic curve of 0.75. Youden's method showed an optimum cut point at -0.5, corresponding to National Institutes of Health Stroke Scale change of greater than or equal to 0 (a lack of clinical improvement), which was seen in 46%. Early neurologic change accurately predicted poor outcome when defined as greater than or equal to 0 (sensitivity, 65%; specificity, 73%; positive predictive value, 70%; adjusted odds ratio, 5.05 [CI, 3.25-7.85]) or greater than or equal to 4 (sensitivity, 19%; specificity, 98%; positive predictive value, 91%; adjusted odds ratio, 12.24 [CI, 4.08-36.66]). All definitions reproduced well in the validation cohort.

CONCLUSIONS: Lack of clinical improvement at 24 hours robustly predicted poor outcome and showed good discrimination for individual patients who would do poorly. These findings are useful for prognostication and may also present as a potential early surrogate outcome for future intracerebral hemorrhage treatment trials.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Yogendrakumar V, Smith EE, Demchuk AM, et al. Lack of Early Improvement Predicts Poor Outcome Following Acute Intracerebral Hemorrhage. Crit Care Med. 2018. PMID: 29303797. doi:10.1097/CCM.0000000000002962

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。